Cytoplasmatic DUSP6 acts as another classical negative regulator of ERK activity with an absolute substrate specificity being consistently overexpressed in response to upregulated ERK signaling in BRAF-mutant melanoma [38]. The gene discussed is BRAF; the disease is melanoma.